Share Email Print
cover

Proceedings Paper

Interstial laser coagulation of benign prostatic hyperplasia: a minimally invasive treatment alternative
Author(s): Robert F. Ordonez; Bernhard T. Mittemeyer; David R. Aronoff; Werner T. W. de Riese
Format Member Price Non-Member Price
PDF $14.40 $18.00
cover GOOD NEWS! Your organization subscribes to the SPIE Digital Library. You may be able to download this paper for free. Check Access

Paper Abstract

The use of minimally invasive treatments for benign prostatic hyperplasia (BPH) have been introduced into the medical community. Over the last decade several minimally invasive treatment techniques have been approved for use. In particular, interstitial laser coagulation (ILC) has shown pomise as an alternative to the current gold standard, transurethral resection of prostate (TURP). Studies show ILC to have equal efficacy as TURP while causing less side effects. Future technical advances as well as increased physician experience with ILC could lead to the replacement of TURP as the gold standard in trestment of BPH.

Paper Details

Date Published: 12 September 2003
PDF: 4 pages
Proc. SPIE 4949, Lasers in Surgery: Advanced Characterization, Therapeutics, and Systems XIII, (12 September 2003); doi: 10.1117/12.476511
Show Author Affiliations
Robert F. Ordonez, Texas Tech Univ. Health Sciences Ctr. (United States)
Bernhard T. Mittemeyer, Texas Tech Univ. Health Sciences Ctr. (United States)
David R. Aronoff, Texas Tech Univ. Health Sciences Ctr. (United States)
Werner T. W. de Riese, Texas Tech Univ. Health Sciences Ctr. (United States)


Published in SPIE Proceedings Vol. 4949:
Lasers in Surgery: Advanced Characterization, Therapeutics, and Systems XIII
Eugene A. Trowers; Timothy A. Woodward; Werner T.W. de Riese; Lawrence S. Bass; Nikiforos Kollias; Udayan K. Shah; Brian Jet-Fei Wong; Reza S. Malek; David S. Robinson; Hans-Dieter Reidenbach; Keith D. Paulsen; Kenton W. Gregory; Lawrence S. Bass; Abraham Katzir, Editor(s)

© SPIE. Terms of Use
Back to Top